Phase I dose-escalation study of oral administration of MET Tyrosine Kinase Inhibitor S 49076 in patients with advanced solid tumours
Phase of Trial: Phase I
Latest Information Update: 29 Sep 2015
At a glance
- Drugs S-49076 (Primary)
- Indications Colorectal cancer; Non-small cell lung cancer; Solid tumours; Uveal melanoma
- Focus Adverse reactions
- Sponsors Servier
- 01 Nov 2013 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials record.
- 23 Oct 2013 Interim results presented at the 25th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics.
- 08 Aug 2013 Planned end date changed from 15 Sep 2015 to 15 Sep 2014 as reported by ISRCTN: Current Controlled Trials record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History